Brief: Acumen Pharmaceuticals, Inc. FY Income From Operations USD -61.138 Million Vs. IBES Estimate USD -58.8 Million
Mar 26 (Reuters) - Acumen Pharmaceuticals, Inc. FY basic EPS USD -1.08. * FY net income USD -52.371 million vs. IBES estimate USD -49.9 million * FY operating expenses USD 61.138 million